Biomerica applies for a PLA code to enhance patient access to its inFoods IBS diagnostic test for personalized IBS management. Biomerica, Inc. has submitted an application to the American Medical ...
Orlando, Fla. — Headquartered in the Netherlands, Total Corbion PLA, a 50-50 joint venture between parent companies Total SA and Corbion NV, has developed a portfolio of polylactic acid resins that ...
IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company ...
The talk delivered by Metabolix Vice President of Biopolymers Bob Engle was also along these lines, with a focus on technology developments in which PHA is used as a modifier for polylactic acid, or ...
The inFoods ® IBS test is a novel, non-invasive diagnostic that identifies patient-specific IBS trigger foods that may be contributing to IBS symptoms such as bloating, abdominal pain, diarrhea, and ...
- inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- ...
IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback